Please login or register first to view this content.
Hematological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
November 2021: 5 Notable Drug Approvals
One-Time Gene Therapy Gets Priority Review for Beta-Thalassemia
Besremi Approved for Adults With Polycythemia Vera
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
Scemblix Approved for Ph+ Chronic Myeloid Leukemia in Chronic Phase
Blood Lead Reference Value in Children Updated to 3.5 µg/dL
FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
FDA Unable to Approve Narsoplimab for HSCT-TMA Without More Data
MPR Weekly Dose Podcast Episode 96
Tecartus Approved for Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease
Jakafi Approved for Chronic Graft-vs-Host Disease
Prophylactic Steroids May Prevent Complications of Thyroidectomy
Voxelotor Gets Priority Review for Pediatric Sickle Cell Disease
Abatacept Gets Priority Review for Moderate to Severe Acute Graft vs Host Disease
Mitapivat Granted Priority Review for Pyruvate Kinase Deficiency
FDA Denies Approval of Roxadustat for Anemia in CKD
Manufacturing Deficiencies Delay Decision on Eflapegrastim
